{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:12:21Z","timestamp":1773270741417,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03396-8","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T13:17:41Z","timestamp":1749215861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive analysis of cuproptosis and m6A-Target gene signatures for diagnostic significance and immune microenvironment characterization in polycystic ovary syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Gengxiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Bie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"3396_CR1","unstructured":"Shukla, A., Rasquin, L. I., Anastasopoulou C.Polycystic Ovarian Syndrome. In: StatPearls (StatPearls Publishing, Treasure Island (FL), 2025). Available at https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK459251\/."},{"key":"3396_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-021-00719-y","volume":"19","author":"T Jain","year":"2021","unstructured":"Jain, T. et al. Characterization of polycystic ovary syndrome among Flo app users around the world. Reprod. Biol. Endocrinol. 19, 1\u201311 (2021).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"3396_CR3","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci. 22, 3789 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"3396_CR4","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger, K. M., Dokras, A. & Piltonen, T. Update on PCOS: consequences, challenges, and guiding treatment. J. Clin. Endocrinol. Metabolism. 106, e1071\u2013e1083 (2021).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"3396_CR5","first-page":"604","volume":"102","author":"M Gibson-Helm","year":"2017","unstructured":"Gibson-Helm, M., Teede, H., Dunaif, A. & Dokras, A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metabolism. 102, 604\u2013612 (2017).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"3396_CR6","doi-asserted-by":"publisher","first-page":"685724","DOI":"10.3389\/fimmu.2021.685724","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment. Front. Immunol. 12, 685724 (2021).","journal-title":"Front. Immunol."},{"key":"3396_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"3396_CR8","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1210\/jc.2011-0651","volume":"96","author":"VM Victor","year":"2011","unstructured":"Victor, V. M. et al. Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J. Clin. Endocrinol. Metabolism. 96, 3115\u20133122 (2011).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"3396_CR9","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.3390\/ijms22083923","volume":"22","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski, S. A. et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int. J. Mol. Sci. 22, 3923 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"3396_CR10","doi-asserted-by":"publisher","first-page":"18487","DOI":"10.1038\/s41598-020-75511-w","volume":"10","author":"S Oc","year":"2020","unstructured":"Oc, S., Eraslan, S. & Kirdar, B. Dynamic transcriptional response of Saccharomyces cerevisiae cells to copper. Sci. Rep. 10, 18487 (2020).","journal-title":"Sci. Rep."},{"key":"3396_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2019.01.008","volume":"365","author":"Y Sun","year":"2019","unstructured":"Sun, Y. et al. High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies. Toxicol. Appl. Pharmcol. 365, 101\u2013111 (2019).","journal-title":"Toxicol. Appl. Pharmcol."},{"key":"3396_CR12","first-page":"3561","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X., Ma, Z. & Mei, L. Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer. Am. J. cancer Res. 12, 3561 (2022).","journal-title":"Am. J. cancer Res."},{"key":"3396_CR13","doi-asserted-by":"publisher","first-page":"1016081","DOI":"10.3389\/fcvm.2022.1016081","volume":"9","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction. Front. Cardiovasc. Med. 9, 1016081 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"3396_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01510-2","volume":"21","author":"LJ Deng","year":"2022","unstructured":"Deng, L. J. et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol. Cancer. 21, 1\u201321 (2022).","journal-title":"Mol. Cancer"},{"key":"3396_CR15","doi-asserted-by":"publisher","first-page":"11874","DOI":"10.1111\/jcmm.15807","volume":"24","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Altered m6A modification is involved in up-regulated expression of FOXO3 in luteinized granulosa cells of non\u2010obese polycystic ovary syndrome patients. J. Cell. Mol. Med. 24, 11874\u201311882 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"3396_CR16","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1096\/fj.202000605RR","volume":"34","author":"C Zhang","year":"2020","unstructured":"Zhang, C., Hu, J., Wang, W., Sun, Y. & Sun, K. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB J. 34, 9563\u20139574 (2020).","journal-title":"FASEB J."},{"key":"3396_CR17","doi-asserted-by":"crossref","unstructured":"Zhou, L. et al. N6-methyladenosine demethylase FTO induces the dysfunctions of ovarian granulosa cells by upregulating flotillin 2. Reprod. Sci. 29, 1305\u20131315 (2022).","DOI":"10.1007\/s43032-021-00664-6"},{"key":"3396_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcp.29912","volume":"236","author":"M Rostamtabar","year":"2021","unstructured":"Rostamtabar, M. et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J. Cell. Physiol. 236, 824\u2013838 (2021).","journal-title":"J. Cell. Physiol."},{"key":"3396_CR19","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3389\/fimmu.2018.02279","volume":"9","author":"VR Moulton","year":"2018","unstructured":"Moulton, V. R. Sex hormones in acquired immunity and autoimmune disease. Front. Immunol. 9, 2279 (2018).","journal-title":"Front. Immunol."},{"key":"3396_CR20","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","volume":"151","author":"Y Zhai","year":"2022","unstructured":"Zhai, Y. & Pang, Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J. Reprod. Immunol. 151, 103628 (2022).","journal-title":"J. Reprod. Immunol."},{"key":"3396_CR21","doi-asserted-by":"publisher","first-page":"938134","DOI":"10.3389\/fphar.2022.938134","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. Front. Pharmacol. 13, 938134 (2022).","journal-title":"Front. Pharmacol."},{"key":"3396_CR22","doi-asserted-by":"crossref","unstructured":"Zhao, Y. et al. Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome. Medicine (Baltimore) 103, e40229 (2024).","DOI":"10.1097\/MD.0000000000040229"},{"key":"3396_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/biology12081101","volume":"12","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y., Tan, J. K. & Goon, J. A. Cuproptosis-and m6A-Related LncRNAs for prognosis of hepatocellular carcinoma. Biology 12, 1101 (2023).","journal-title":"Biology"},{"key":"3396_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The Sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"3396_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen, S. & Bohlin, J. Statistical predictions with Glmnet. Clin. Epigenetics. 11, 123 (2019).","journal-title":"Clin. Epigenetics"},{"key":"3396_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinform. 12, 1\u20138 (2011).","journal-title":"BMC Bioinform."},{"key":"3396_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J. Integr. Biology. 16, 284\u2013287 (2012).","journal-title":"Omics: J. Integr. Biology"},{"key":"3396_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/atm.2017.04.01","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. & Kattan, M. W. Drawing nomograms with R: applications to categorical outcome and survival data. Annals Translational Med. 5, 211 (2017).","journal-title":"Annals Translational Med."},{"key":"3396_CR29","doi-asserted-by":"publisher","first-page":"e31325","DOI":"10.1097\/MD.0000000000031325","volume":"101","author":"H Li","year":"2022","unstructured":"Li, H. et al. Decision curve analysis to identify optimal candidates of liver resection for intermediate-stage hepatocellular carcinoma with hepatitis B cirrhosis: A cohort study. Medicine 101, e31325 (2022).","journal-title":"Medicine"},{"key":"3396_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer Immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint Blockade. Cell. Rep. 18, 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"key":"3396_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"3396_CR32","doi-asserted-by":"crossref","unstructured":"Group, R. E. A. S. P. C. W. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction. 19, 41\u201347 (2004).","DOI":"10.1093\/humrep\/deh098"},{"key":"3396_CR33","first-page":"2","volume":"53","author":"E Panel","year":"2018","unstructured":"Panel, E. Chinese guideline for diagnosis and management of polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi. 53, 2\u20136 (2018).","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"3396_CR34","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41598-022-27326-0","volume":"13","author":"Z Su","year":"2023","unstructured":"Su, Z., Su, W., Li, C., Ding, P. & Wang, Y. Identification and immune features of cuproptosis-related molecular clusters in polycystic ovary syndrome. Sci. Rep. 13, 980 (2023).","journal-title":"Sci. Rep."},{"key":"3396_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-023-01147-9","volume":"16","author":"S Zhou","year":"2023","unstructured":"Zhou, S., Hua, R. & Quan, S. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in polycystic ovary syndrome (PCOS). J. Ovarian Res. 16, 1\u201315 (2023).","journal-title":"J. Ovarian Res."},{"key":"3396_CR36","doi-asserted-by":"publisher","first-page":"1094793","DOI":"10.3389\/fgene.2023.1094793","volume":"14","author":"H Qin","year":"2023","unstructured":"Qin, H. et al. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. Front. Genet. 14, 1094793 (2023).","journal-title":"Front. Genet."},{"key":"3396_CR37","doi-asserted-by":"crossref","unstructured":"Yu, H. et al. A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer. Transl. Cancer Res. 12, 1392\u20131410 (2023).","DOI":"10.21037\/tcr-22-2702"},{"key":"3396_CR38","doi-asserted-by":"crossref","unstructured":"Lin, K. et al., FTO Deubiquitinated by USP7 Influenced NEDD4 mRNA Stability Enhancing the Chemoresistance of Pancreatic Cancer to Gemcitabine by Promoting Cell Proliferation and Regulating PTEN\/PI3K\/AKT Pathway. Available at SSRN 4258954. (2022).","DOI":"10.2139\/ssrn.4258954"},{"key":"3396_CR39","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.21037\/tcr-22-1335","volume":"11","author":"Z Yu","year":"2022","unstructured":"Yu, Z., He, Q. & Xu, G. Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer. Translational Cancer Res. 11, 4303 (2022).","journal-title":"Translational Cancer Res."},{"key":"3396_CR40","doi-asserted-by":"crossref","unstructured":"Hu, Y. et al. Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer. Biochem. Genet. 62, 40\u201358 (2024).","DOI":"10.1007\/s10528-023-10406-9"},{"key":"3396_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1021\/pr050391m","volume":"5","author":"Y Wang","year":"2006","unstructured":"Wang, Y. et al. Proteomic analysis reveals novel molecules involved in insulin signaling pathway. J. Proteome Res. 5, 846\u2013855 (2006).","journal-title":"J. Proteome Res."},{"key":"3396_CR42","first-page":"6560","volume":"10","author":"Y Ma","year":"2017","unstructured":"Ma, Y. et al. Long noncoding RNA H19 inhibits the growth and invasion of trophoblasts by inactivating Wnt\/beta-catenin signaling via downregulation of DDX3X. Int. J. Clin. Exp. Pathol. 10, 6560\u20136567 (2017).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"3396_CR43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.5114\/aoms.2019.89254","volume":"17","author":"L Li","year":"2021","unstructured":"Li, L., Wei, J., Hei, J., Ren, Y. & Li, H. Long non-coding RNA H19 regulates proliferation of ovarian granulosa cells via STAT3 in polycystic ovarian syndrome. Archives Med. Science: AMS. 17, 785 (2021).","journal-title":"Archives Med. Science: AMS"},{"key":"3396_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/molehr\/gap103","volume":"16","author":"S Koks","year":"2010","unstructured":"K\u00f5ks, S. et al. The differential transcriptome and ontology profiles of floating and cumulus granulosa cells in stimulated human antral follicles. Mol. Hum. Reprod. 16, 229\u2013240 (2010).","journal-title":"Mol. Hum. Reprod."},{"key":"3396_CR45","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.7150\/ijbs.69771","volume":"18","author":"J Chen","year":"2022","unstructured":"Chen, J., Fang, Y., Xu, Y. & Sun, H. Role of m6A modification in female infertility and reproductive system diseases. Int. J. Biol. Sci. 18, 3592 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"3396_CR46","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1002\/biof.2142","volume":"51","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. Navigating the immune landscape with plasma cells: A pan-cancer signature for precision immunotherapy. BioFactors 51, e2142 (2025).","journal-title":"BioFactors"},{"key":"3396_CR47","doi-asserted-by":"crossref","unstructured":"Ye, B. et al., iMLGAM: Integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction. iMeta. e70011 (2025).","DOI":"10.1002\/imt2.70011"},{"key":"3396_CR48","doi-asserted-by":"publisher","first-page":"101865","DOI":"10.1016\/j.tranon.2023.101865","volume":"40","author":"W Sun","year":"2024","unstructured":"Sun, W. et al. Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma. Translational Oncol. 40, 101865 (2024).","journal-title":"Translational Oncol."},{"key":"3396_CR49","doi-asserted-by":"publisher","first-page":"958368","DOI":"10.3389\/fimmu.2022.958368","volume":"13","author":"Q Song","year":"2022","unstructured":"Song, Q., Zhou, R., Shu, F. & Fu, W. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer. Front. Immunol. 13, 958368 (2022).","journal-title":"Front. Immunol."},{"key":"3396_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cca.2022.04.234","volume":"531","author":"Y Luan","year":"2022","unstructured":"Luan, Y., Zhang, L., Peng, Y., Li, Y. & Liu, R. x.& Yin, C.-h. Immune regulation in polycystic ovary syndrome. Clin. Chim. Acta. 531, 265\u2013272 (2022).","journal-title":"Clin. Chim. Acta"},{"key":"3396_CR51","doi-asserted-by":"crossref","unstructured":"Fan, G. et al. Genes associated with N6-methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma. Environ. Toxicol. 39, 626\u2013642 (2024).","DOI":"10.1002\/tox.23920"},{"key":"3396_CR52","doi-asserted-by":"publisher","first-page":"923737","DOI":"10.3389\/fgene.2022.923737","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front. Genet. 13, 923737 (2022).","journal-title":"Front. Genet."},{"key":"3396_CR53","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/j.fertnstert.2019.07.748","volume":"112","author":"L Yubing","year":"2019","unstructured":"Yubing, L., Xinmei, L., Xiaocan, L. & Chian, R. Effect of Adriamycin, bleomycin, vinblastine and Dacarbazine (ABVD) treatment on female mice reproductive function. Fertil. Steril. 112, e246 (2019).","journal-title":"Fertil. Steril."},{"key":"3396_CR54","first-page":"165","volume":"32","author":"M McLaughlin","year":"2017","unstructured":"McLaughlin, M., Kelsey, T. W., Wallace, W., Anderson, R. & Telfer, E. Non-growing follicle density is increased following Adriamycin, bleomycin, vinblastine and Dacarbazine (ABVD) chemotherapy in the adult human ovary. Hum. Reprod. 32, 165\u2013174 (2017).","journal-title":"Hum. Reprod."},{"key":"3396_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.placenta.2012.11.032","volume":"34","author":"K Rull","year":"2013","unstructured":"Rull, K. et al. Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage. Placenta 34, 141\u2013148 (2013).","journal-title":"Placenta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03396-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03396-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03396-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T16:03:29Z","timestamp":1749225809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03396-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3396"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03396-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of the Second Affiliated Hospital of Kunming Medical University (No.2023 \u2212\u2009238). All participants provided written informed consent. We confirm that all methods were performed in accordance with the relevant guidelines. All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"19996"}}